This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Acyclovir in pregnancy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • accumulated evidence for the safety of oral acyclovir and valacyclovir does not demonstrate an increase in the rate of major birth defects when compared with the general population or an unexposed group

  • topical antiviral preparations of acyclovir and penciclovir resulted in no increased rate of major birth defects during pregnancy

  • evidence suggests it is reasonable to offer pregnant patients either acyclovir or valacyclovir for treatment of primary or recurrent genital HSV infection, which not only treats the mother's condition, but also reduces the likelihood of transmission to the neonate, without unduly compromising fetal safety.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.